Search results
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 4 days agoThe institutional investor owned 3,028 shares of the company’s stock after selling 261 shares during the quarter. Wealthspire Advisors LLC’s holdings in Moderna< ...
Moderna shares target raised to $85 by Deutsche Bank By Investing.com
Investing.com· 7 days agoThe adjustment follows a review of Moderna's first-quarter performance, which reported steady...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 7 days agoTake risks for example - Moderna has 1 warning sign we think you should be aware of. If you are like...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 15 hours agoIn the first quarter, Halozyme earned an adjusted 79 cents per share on $196 million in sales, up a...
Why This Small Diagnostics Name Is 'A Stock To Focus On'
Investor's Business Daily· 5 days agoThe March quarter benefited from increases in test volume and average selling price for tests in the...
These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital,...
Barrons.com· 5 days agoNovavax stock surged after the vaccine maker signs a $1.2 billion licensing deal with France’s...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 7 days agoThe Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. *Stock Advisor...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters via AOL· 6 days agoThe Maryland-based drugmaker's stock more than doubled in Friday trading to $8.97 following the deal...
Lonza stock holds Buy rating with higher target By Investing.com
Investing.com· 2 days agoThe firm's valuation is based on a multiple of 25 times the expected EBITDA for 2024 or 22.5 times...